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Abstract: Excessive administration of 0.9% normal saline (NS) can cause hyperchloremic metabolic acidosis dur-
ing surgery. It was hypothesized that intraoperative administration of 0.9% NS by goal-directed fluid management 
based on stroke volume variation (SVV) could alleviate metabolic acidosis, compared to central venous pressure 
(CVP) based fluid management. Forty-eight patients, scheduled for elective craniotomy, were randomly allocated to 
CVP or stroke volume variation (SVV) groups. Cut-off values to challenge the fluids were set at 5 mmHg in the CVP 
group and 13 in the SVV group, respectively. Arterial blood samples were taken at T1 (immediately after induction), 
T2 (4 hours after induction), and T3 (at the end of surgery). The pH, standard base excess, and sum of all anion 
charges of weak plasma acid values at T2 and T3 were significantly lower than values at T1 in both groups. Apparent 
strong iron differences at T2 and T3 in the CVP group were significantly lower than those in T1, while there were 
no significant differences between time points in the SVV group. Lactate levels were significantly greater at T2 and 
T3 than at T1 in both groups. All measured values at each time point and interactions between the groups were 
comparable. In conclusion, intraoperative goal-directed administration of 0.9% NS did not alleviate the severity of 
metabolic acidosis, compared to CVP-guided fluid therapy, in patients undergoing brain tumor surgeries.
Keywords: Central venous pressure, goal-directed fluid management, metabolic acidosis, normal saline, stroke 
volume variation
Introduction
During brain surgery, intraoperative fluid man-
agement must be carefully controlled to pre-
serve cerebral perfusion pressure [1]. Hypovo- 
lemia can cause inadequate cerebral perfu-
sion, while fluid overload can result in brain 
edema and increased intracranial pressure. In 
general, balanced isotonic fluid is preferred to 
0.9% normal saline (NS) for intraoperative fluid 
management. Administration of large volumes 
of 0.9% NS can result in metabolic acidosis, pri-
marily caused by hyperchloremia [2]. However, 
0.9% NS is still widely used in neurosurgery 
since it is not expected to contribute to cerebral 
edema induced by serum hypo-osmolality [3-5].
Static measurements of intravascular pres-
sure, such as central venous pressure (CVP) 
and pulmonary artery occlusion pressure, gen-
erally reflect ventricular preload. However, ac- 
cording to current studies, there is no predict-
able relationship between these parameters 
and volumetric preload indices or cardiac per-
formance variables [2, 6]. Additionally, dynamic 
indices, such as stroke volume variation (SVV) 
and pulse pressure variation, have emerged as 
alternatives guiding fluid administration [7]. 
Previous studies have revealed the efficacy of 
goal-directed intraoperative fluid therapy based 
on the use of dynamic indices, showing fewer 
complications [8] and better outcomes [9] for 
several surgery types. However, few studies 
have evaluated acid-base profiles after the use 
of goal-directed fluid therapy.
This study was designed to test whether in- 
traoperative goal-directed fluid management 
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using 0.9% NS administration guided by SVV 
could alleviate metabolic acidosis in patients 
undergoing craniotomy and brain tumor re- 
moval, compared with fluid administration ba- 
sed on CVP. It was hypothesized that a fluid 
administration strategy based on the dynamic 
index might prevent either the degree of aci- 
dosis caused by hypervolemia with excessive 
chloride or lactic acidosis caused by hypovole-
mia with poor tissue perfusion. 
Materials and methods
Patients
This prospective and randomized controlled 
study was performed after obtaining appro- 
val from the Institutional Review Board of 
Severance Hospital, Yonsei University Health 
System in Seoul, Republic of Korea. The study 
is registered at www.clinicaltrials.gov (Registr- 
ation number: NCT01738880).
Fifty patients, scheduled for elective cranioto-
my and brain tumor removal, were enrolled in 
this study between July 2013 and June 2014. 
Patients between 20-65 years of age and with 
American Society of Anesthesiologists physical 
status scores of I-III were eligible. Patients with 
New York Heart Association functional classifi-
cations of III-IV, severe obstructive or restrictive 
lung disease, end-stage liver or kidney diseas-
es, diabetes, pre-existing metabolic acidosis, 
or symptoms and signs of increased intracr- 
anial pressure were excluded from the study. 
Written informed consent was obtained from 
all patients before enrollment. 
Before surgery, each patient was randomly allo-
cated to one of two groups (CVP or SVV group). 
The anesthesiologist responsible for intraoper-
ative care was aware of the treatment group for 
each patient. Other members of the research 
team and participants were blinded to treat-
ment group assignments. 
Anesthetic management
Each patient was premedicated with intrave-
nous glycopyrrolate (0.2 mg) before induction 
of anesthesia. In the operating room, each 
patient received routine monitoring consisting 
of non-invasive blood pressure measurement, 
pulse oximetry, electrocardiography, and cap-
nography. General anesthesia was induced 
using intravenous propofol (1.5 mg/kg) with 
remifentanil (1 µg/kg) and inhalation of se- 
voflurane (2-3 vol%). Endotracheal intubation 
was performed after ample muscle relaxation, 
obtained by administration of rocuronium bro-
mide (0.8 mg/kg). Anesthesia was maintained 
using sevoflurane (1-2 vol%) and infusion of 
remifentanil (0.05-0.1 µg/kg/min), targeting a 
Bispectral index (BIS VISTATM, Aspect Medical 
Systems, Norwood, MA, USA) between 40 and 
60. Ventilation was mechanically controlled 
using a tidal volume of 8 mL/kg of ideal body 
weight and a respiratory rate of 8-12 breaths/
minute to maintain an end-tidal carbon dioxide 
concentration of 30-35 mmHg. An esophageal 
temperature probe was inserted and core body 
temperature was maintained at 36-37°C us- 
ing a warm air blanket. Muscle relaxation was 
maintained using rocuronium infusions and 
train-of-four count monitoring during surgery to 
prevent patient movement. For continuous 
blood pressure monitoring and blood samp- 
ling, an arterial catheter used was inserted 
into the radial artery and a central venous 
catheter was inserted into the femoral vein. In 
the SVV group, the Vigileo-FloTracTM System 
(Edwards Lifesciences, Irvine, California, USA) 
was connected to the invasive arterial blood 
pressure monitor for continuous SVV monitor-
ing. The pressure transducer of arterial blood 
pressure and CVP measurement was zeroed at 
the level of the mid-axillary line at the begin- 
ning of surgery. 
Intraoperative fluid management with 0.9% 
NS or 6% hydroxyethyl starch in 0.9% NS 
(Voluven®, Fresenius Kabi Deutschland GmbH, 
Bad Homberg, Germany) was conducted, fol-
lowing standard protocol for each treatment 
group (Figure 1). The maximal limit of 6% 
hydroxyethyl starch administration was 50 mL/
kg. Ephedrine or phenylephrine was adminis-
tered intravenously in cases of low mean arte-
rial pressure (<65 mmHg) despite appropriate 
CVP or SVV values. Transfusion of packed red 
blood cells was performed when hemoglobin 
declined below 8 g/dL or when an acute mas-
sive bleeding event occurred. Before transfu-
sion, compensation of intravascular volume 
loss due to bleeding was accomplished using 
the same amount of 6% hydroxyethyl starch 
solution. Upon the surgeon’s request, 0.5-1.0 
g/kg of mannitol was administered intraven- 
ously.
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At 30 minutes before the end of the surgery, 
each patient received 1 µg/kg of fentanyl for 
postoperative pain control and 0.3 mg of ramo-
setron for prevention of postoperative nausea 
and vomiting. Neuromuscular blockade was re- 
versed at the end of surgery using 0.04 mg/kg 
of neostigmine and 0.2 mg of glycopyrrolate. 
If conditions of the patient did not meet the 
criteria for extubation or the surgeon did not 
approve of extubation, the patient was trans-
ferred to the Neurosurgical Intensive Care Unit 
without anesthetic emergence and extubation.
Measurements and calculations
An arterial blood sample was taken at three 
time points: (T1) immediately after induction, 
(T2) 4 hours after induction, and (T3) at the end 
of surgery. Samples were analyzed for pH, 
PaCO2, lactate, Na
+, K+, Ca2+, Mg2+, and Cl- using 
a blood gas analyzer and for serum concentra-
tions of phosphate and albumin. Values for 
standard base excess (SBE) and bicarbonate 
levels were calculated using the Henderson-
Hasselbalch and Van Slyke equations, respec-
tively. Since the classical approach often inad-
equately explains certain causes of acid-base 
derangement, parameters that determine met-
abolic acid-base status were calculated using 
Stewart’s approach [10]. Parameters and ab- 
breviations used in this study are presented in 
Table 1.
ent’s t-test. Mann-Whitney rank-sum test for 
continuous variables and χ2 test and Fisher’s 
exact test for categorical variables were ap- 
plied, as appropriate. A linear mixed model 
(LMM) was used to assess changes in param-
eters related to acid-base status over time. All 
P values <0.05 are considered statistically sig-
nificant. Statistical analyses were performed 
using SAS® software, version 9.2 (SAS Institute 
Inc, Cary, NC, USA).
Results
Forty-eight of the 50 enrolled patients complet-
ed this study. Two patients (one patient from 
each treatment group) had metabolic acidosis 
(SBE <5.0 mEq/L) at baseline and were exclud-
ed. Patient characteristics were similar between 
the two groups (Table 2). Intraoperative results 
are presented in Table 3. Colloid and ephedrine 
were administered to more patients in the CVP 
group than the SVV group. There were no other 
significant differences between the two groups. 
Results for acid-base status, including pH, 
PaCO2, and SBE, are presented in Figure 2. 
There were no significant changes in PaCO2 
over time in either group (Figure 2B). However, 
in both groups, pH values at T2 and T3 were 
significantly lower than those at T1 (Figure 2A). 
SBE values were significantly decreased at T2 
and T3 in both groups, compared with baseline 
Figure 1. The protocol of fluid management in each group. CVP = central 
venous pressure; MAP = mean arterial pressure; NS = normal saline; SVV = 
stroke volume variation.
Statistical analyses
The primary endpoint of this 
study was to compare differ-
ences in SBE at the end of 
surgery (T3). Based on a pre-
vious study regarding SBE, in 
which a between-group differ-
ence of over than 50% was 
clinically significant [11], 25 
patients were required in ea- 
ch group to achieve a two-sid-
ed α=0.05 with 90% power 
and a 10% of drop-out rate. 
Distribution of data was as- 
sessed using the one-sample 
Kolmogorov-Smirnov test. Re- 
sults are presented as mean 
± standard deviation (SD) or 
median (interquartile range). 
Between-group comparisons 
were performed using Stud- 
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Table 1. Abbreviations and calculations
Abbreviation Definition Calculation
SIDa Apparent strong iron difference Na+ + K+ + Ca2+ + Mg2+ - Cl- - Lactate-
SIDe Effective strong iron difference HCO3
- + Alb- + Pi-
SIG Strong iron gap SIDa - SIDe
ATOT Sum of all anion charges of weak plasma acid Alb
- + Pi-
Alb- Negative charges of serum albumin Serum albumin concentration [g/L] X (0.123 X pH - 0.631)
Pi- Negative charges of inorganic phosphate Serum phosphate concentration [mmol/L] X (0.309 X pH - 0.469)
Table 2. Patient characteristics
CVP group (n=24) SVV group (n=24) P-value
Age (y) 54 (43-60) 50 (39-57) 0.445
Height (cm) 159 (155-170) 164 (158-172) 0.142
Weight (kg) 62 (56-74) 64 (57-70) 0.820
Body mass index (kg/m2) 25 ± 2 24 ± 2 0.115
Sex (M/F) 7/17 9/15 0.760
ASA (I/II) 10/14 13/11 0.564
Tumor type (M/C/G/S)* 13/2/8/1 16/2/6/0 0.814
Preoperative mannitol (n) 13 (54.2%) 9 (37.5%) 0.385
Values are expressed as a median (IQR), mean ± SD, or number of patients (percentage). 
*M, meningioma; C, craniopharyngioma; G, glioma; S, schwannoma.
Table 3. Intraoperative data
CVP group (n=24) SVV group (n=24) P-value
Anesthesia time (min) 505 (465-550) 467 (393-571) 0.201
Surgery time (min) 395 (360-467) 373 (327-510) 0.523
Crystalloid (mL) 3900 (3000-4400) 3725 (3138-5175) 0.992
Colloid (mL) 400 (0-500) 0 (0-150) 0.027
Packed RBC transfusion (mL) 0 (0) 0 (0) 0.704
Urine output (ml) 1590 (1310-2490) 1865 (1158-3072) 0.934
Estimated blood loss (ml) 700 (500-1250) 615 (313-915) 0.140
Phenylephrine dose (mg) 0 (0-1.8) 0 (0-6) 0.245
Ephedrine dose (mg) 12 (6-24) 5 (0-16) 0.028
MBP (mmHg)
    T1 76.1 ± 13.8 73.8 ± 12.5 0.549
    T2 73.1 ± 6.3 74.1 ± 9.9 0.666
    T3 74.0 ± 8.5 75.0 ± 9.0 0.706
HR (beats/min)
    T1 64.5 ± 11.3 66.9 ± 12.8 0.484
    T2 73.8 ± 11.4 68.3 ± 11.2 0.096
    T3 76.0 ± 14.6 70.7 ± 8.8 0.130
Hemoglobin (g/dL)
    T1 12.1 ± 1.0 12.4 ± 1.2 0.438
    T3 10.9 ± 0.9 11.3 ± 1.3 0.163
Intraoperative mannitol (n) 18 (75%) 23 (95.8%) 0.097
Values are expressed as a median (IQR) or mean ± SD or number of patients (percent-
age). T1: immediately after induction; T2: 4 hours after induction; T3: at the end of the 
surgery.
values (Figure 2C). SBE 
values in the CVP group 
were greater than those 
in the SVV group, espe-
cially at T3. However, 
there were no differenc-
es in any parameter at 
each time point betw- 
een the groups. Changes 
in SBE over time were 
not significantly different 
between the two gro- 
ups. Results for other 
variables that can affe- 
ct acid-base status are 
presented in Table 4. Al- 
though there were chan- 
ges in Na+, Cl-, and albu-
min values at each time 
point for each group, th- 
ere were no significant 
between-group differen- 
ces. 
In Figure 3, changes in 
parameters that can de- 
termine acid-base status 
are presented. Apparent 
strong iron difference 
(SIDa) values at T2 and 
T3 in the CVP group were 
significantly lower than 
at T1. However, there we- 
re no significant chang- 
es in SIDa for any time 
points in SVV group pa- 
tients (Figure 3A). The 
sum of all anion charges 
of weak plasma acid 
(ATOT) at T2 and T3 de- 
creased from that at T1 
in each group (Figure 
3B). At T2 and T3, lactate 
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levels were significantly greater than those at 
T1, while levels were highest at T2 in each 
group (Figure 3C). There were no significant dif-
ferences in strong iron gap (SIG) levels among 
the time points for either group (Figure 3D). 
There were also no significant differences be- 
tion of fluids or diuretics. In the past, interna-
tionally endorsed clinical guidelines [12] recom-
mended using CVP as a reference of appropri-
ate fluid resuscitation. Although there is contro-
versy about its benefits regarding outcomes, 
one of the goals of early goal-directed therapy 




    CVP group 138.1 ± 3.7 138.8 ± 3.8 140.0 ± 3.5*
    SVV group 137.9 ± 2.5 139.1 ± 2.7 140.3 ± 2.6*
Cl- (mmol/L)
    CVP group 110.5 ± 3.5 113.3 ± 3.3* 114.8 ± 3.4*
    SVV group 111.1 ± 3.2 113.2 ± 2.9* 115.1 ± 3.2*,†
Albumin (g/L)
    CVP group 35.7 ± 4.8 29.6 ± 3.3* 28.8 ± 2.9*
    SVV group 34.6 ± 3.8 30.8 ± 4.9* 29.7 ± 4.4*
Values are expressed as a mean ± SD. *P<0.05 vs. T1 within group; 
†P<0.05 vs. T2 within group. T1: immediately after induction; T2: 4 
hours after induction; T3: at the end of the surgery.
Figure 2. Acid-base status during study periods. 
A. Changes in pH values at each time point. B. 
Changes in carbon dioxide at each time point. 
C. Changes in standard base excess (SBE) at 
each time point. *P<0.05 vs. T1 within group; 
†P<0.05 vs. T2 within group; ‡P<0.05 vs. SVV 
group at the same time point. (T1: immediately 
after induction; T2: 4 hours after induction; T3: 
at the end of the surgery).
tween the two groups at each time point or 
in interactions between the groups. 
Discussion
The primary outcome of this study was to 
evaluate whether goal-directed fluid man-
agement using SVV could alleviate the 
severity of metabolic acidosis after intra-
operative 0.9% NS infusion in patients 
undergoing brain tumor surgeryies, com-
pared with CVP-guided fluid management. 
The current study revealed that, compar- 
ed to CVP, SVV-guided fluid management 
did not improve metabolic acidosis. 
Conventionally, CVP is frequently used to 
make decisions regarding the administra-
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in patients with severe sepsis is aggressive vol-
ume resuscitation in the initial phase. CVP has 
been suggested as a method to achieve this 
goal [12, 13]. The basis for using CVP to guide 
fluid management comes from the dogma that 
CVP reflects intravascular volume. Specifically, 
it is widely believed that patients with a low 
CVP are volume depleted, while patients with a 
high CVP are volume overloaded [14]. However, 
CVP has been recognized as a less effective 
value for fluid management over recent deca- 
des because an individual’s normal CVP values 
can vary with ventricular function and changes 
in CVP response do not necessarily reflect fluid 
responsiveness [2]. 
Many studies have reported positive outcomes 
of dynamic indices, based on heart-lung inter-
actions during mechanical ventilation, assess-
ing fluid responsiveness. Specifically, systolic 
pressure variation (SPV) and pulse pressure 
variation (PPV), derived from analysis of the 
arterial waveform, and stroke volume variation 
(SVV), derived from pulse contour analysis, 
have been shown to be predictive of fluid res- 
ponsiveness [15]. These values correlate well 
with a patient’s volume responsiveness, com-
pared to CVP. In addition, fluid management 
based on these indices shows better post- 
operative outcomes [9, 16-18] and less periop-
erative complications [8]. In particular, SVV val-
ues obtained from the Vigileo-FloTracTM system 
have been assessed and accepted as clinical- 
ly useful and reliable indicators for fluid optimi-
zation in several types of operations [7, 19, 20]. 
Hyperchloremic metabolic acidosis also can 
result in poorer outcomes in patients undergo-
ing brain surgery [21]. Hyperchloremia indu- 
ced by 0.9% NS administration has been asso-
ciated with gastrointestinal symptoms, ranging 
from nausea to abdominal pain, renal dysfunc-
Figure 3. Measured and calculated values during study periods. A. Changes in apparent strong iron difference 
(SIDa) at each time point. B. Changes in the sum of all anion charges of weak plasma acid (ATOT) at each time point. 
C. Changes in lactate at each time point. D. Changes in strong iron gap (SIG) at each time point. *P<0.05 vs. T1 
within group. (T1: immediately after induction; T2: 4 hours after induction; T3: at the end of the surgery).
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tion, and coagulation abnormalities. Serum lac-
tate elevation is an indicator of lower tissue 
hypoperfusion, indicating the presence of glob-
al tissue hypoxia and even shock status [22]. 
Lactic acidosis, a major source of metabolic 
acidosis, has been reported to be associated 
with higher mortality [23, 24]. Therefore, the 
aim of this study was to find a strategy that 
could be used to reduce metabolic acidosis 
that occurs after 0.9% NS use in patients un- 
dergoing brain surgery. Although study results 
did not indicate how intraoperative metabolic 
acidosis affected outcomes in patients under-
going brain surgery, it was expected that fluid 
management guided by SVV could be used to 
maintain normovolemia, thus preventing either 
hyperchloremic metabolic acidosis or lactic 
acidosis. 
According to Stewart’s approach, there are only 
three parameters that independently deter-
mine the hydrogen ion, PaCO2, SIDa, and ATOT 
[25]. Because PaCO2 is regulated by respira-
tion, metabolic acid-base disturbances are 
caused by changes in SIDa or ATOT. Additional 
strong anions, such as lactate and SIG (unmea-
sured anions including formate, ketoacids, 
salicylate, sulfate, etc.), contribute to metabo- 
lic acidosis under pathologic conditions [25]. 
Present results indicate that SIDa decreased 
from T1 to T3 and that lactate increased from 
T1 to T3, resulting in a decrease in SBE. There 
were no significant changes in SIG between 
time points. The decrease in ATOT from T1 to T3 
may have been due to decreases in albumin 
during the same time period. The decrease in 
ATOT reduced the magnitude of the SBE decre- 
ase. SIDa decreases are partially explained by 
an increase in chloride from T1 to T3, which 
may be induced by 0.9% NS administration. 
Because ATOT changes largely result from a 
change in albumin levels [25], intraoperative 
loss or dilution of albumin may have caused 
the changes in ATOT. However, no differences be-
tween the CVP and SVV groups in any of the 
parameters can affect metabolic acid-base dis-
turbances. Although SBE in the CVP group was 
significantly higher than in the SVV group at T3, 
the SBE value for the CVP group started at a 
higher level than that of the SVV group, with no 
significant differences.
The current study had several limitations. First, 
the CVP value used for fluid management of 
the CVP group patients was measured using a 
catheter inserted at the femoral vein. This is 
routine practice for brain surgery at the insti- 
tution. Placement of CVP at the femoral vein 
measures pressure from the common iliac vein 
or the inferior vena cava [26]. However, mea-
surement of pressure at the inferior vena cava 
or common iliac vein is only partly reliable for 
measurement of right atrial pressure. Also, the 
5 mmHg of cut-off value, which was referenced 
to guide normovolemia [27], may have caused 
different results compared to the typically used 
value of 8-12 mmHg. Second, SVV values that 
are not externally calibrated may not be accu-
rate. The algorithms of SVV have been impro- 
ved over four generations and accuracy has 
improved with every generation. However, the 
trending and inadequate cardiac output dis-
criminating abilities with the fourth generation 
FloTrac for cardiac output monitoring are not 
statistically acceptable [28]. Even without sur-
gical stress, application of the fourth genera-
tion FloTrac on an anesthetized critically ill 
patient is not ideal [28]. However, it is impera-
tive to recall that this problem was also pre- 
sent in FloTrac before the fourth generation 
and postoperative outcomes of patients based 
on prior generation SVV measurements were 
superior to those based on CVP values for pre-
dicting fluid response. Finally, the sample size 
may have been insufficient to document dif- 
ferences in acid-base profiles between study 
groups. 
In conclusion, compared to CVP-guided fluid 
therapy, intraoperative goal-directed fluid ther-
apy with 0.9% NS based on SVV values from 
the Vigileo-FloTracTM system did not alleviate 
the severity of metabolic acidosis in patients 
undergoing brain tumor resections. 
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